US-based CRO, Veristat, is expanding its service capabilities by acquiring SFL (Solutions for Life Sciences). With headquarters in Switzerland, SFL brings experience in providing strategic advice and operational support for all stages of product development across a broad range of product types including small molecules, biologics, drug-device combination products, medical devices, in vitro diagnostics (IVDs) and…
Home Healthcare Markets International News Switzerland: Veristat acquires competitive advantage in Europe with Solutions for Life Sciences